Drug Repurposing Candidates for Type 1 Diabetes Mellitus Identified by Single-Cell RNA Sequencing of Peripheral Blood Mononuclear Cells with Monocyte-Focused Transcriptomic Analysis

Read full text Summarise with VIRAT
Authors: Glen Charles Ritschel, Claude
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Provisional patent specification disclosing drug repurposing candidates for T1DM identified by scRNA-seq of PBMCs (GSE221297, n=12 donors, 60k cells). Monocyte clusters 11/12/13/16 yielded 2,749 DE genes; LINCS L1000 analysis identified Na+/K+-ATPase inhibitors (digitoxigenin, ouabain, bufalin, cinobufagin, cymarin, sarmentogenin) as top candidates with cross-disease signal for QL-XII-47.

Fields of Study & Subjects

Diabetes and associated disorders Single-cell and spatial transcriptomics Pancreatic function and diabetes

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
28 March 2026
Language
EN